{"name":"AIM ImmunoTech Inc.","slug":"aim-immunotech-inc","ticker":"","exchange":"","domain":"","description":"AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5INmJER1ZydWpkOFNaMi1PRmgwT3BxRkxXeTRpeFNCeUF1X09GX3lwRTgzb1p2NHlON2Y4Z3JhS1c1QlU5bHFYQXNwZTNyc3I3eVZsSHAtc08yS2J3b3VsQmxaN2toMHVsLVY2Tg?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Aim Immunotech (AIM) - Stock Titan","headline":"If You Invested $1,000 in Aim Immunotech (AIM)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOQm9BS3JweDduVU8wRjNEaGlvNWtEeW5Lc0tiUlB3M29Ba0tEeTlZcnhMSXhOaDhBYWFBcUhDTkoxcVoxRjRVR1lvOWNQdHpaU0tQZlRaQ1Z6ZzZYSllvcEY4dkVIdC1GaDRMbjByWmh6WUpqTjUtSnozUDNHVXpaZ3RpcE82Yl8zbVZ3V2hNclQzcVBMSXZab19rVHNqblJ3M3d3al9IQjh6U3NPT1ItV1pMVDZvbm1MZFhvLWg0bTNKbDZldFJQUWpoNA?oc=5","date":"2026-03-06","type":"pipeline","source":"GlobeNewswire","summary":"AIM ImmunoTech Announces Closing of its Rights Offering - GlobeNewswire","headline":"AIM ImmunoTech Announces Closing of its Rights Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxPZGZKZkRId2hZYTE1U2ttLVV3ZEEyRlB6WGl1dGJvZlE5Znd1Z05SaFhhSWRYLXhyaGdUVHo1YjJEbEswMTE0d25YcHVVdkE2SWJWdkJ2RUl5ZFJtRUx0dS1CVmYzUFl4MjFuSzV0clBaUkxWUUkwTy1NV25NSjFlVExwa1Z6MDVHa3ZyUkR5dUM4ZTJqUmd1TVpFZmRvWEVZWVUwekMtYXZyd05pN2lDZzg5QkxtN2RYRjFRYjdJaXVFS2JRNERaOUxQZUVnbTdoRUhjQ0xSTkNaOHRBd09oam1OUk5mZkdsU2VwUGR6MmhPakhNYUxva1R1UTh4OTgzYUZQWTRyN0RHOWF3X2JYYXJ0RUlMMFF0djRIQUVWMnVrb3VlbTBqNVhR?oc=5","date":"2026-03-04","type":"patent","source":"GlobeNewswire","summary":"AIM ImmunoTech Announces Expiration and Preliminary Results - GlobeNewswire","headline":"AIM ImmunoTech Announces Expiration and Preliminary Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxPRUNQRTZtWUFJMDI5aVczRGc5Z3dqNXFOa2Fod09sY1hBZ0tSYmUwbFpnaUF3VVAtVHhySnV0X0hSYTE0RG1RSlJ0dEd3MjhENl9LYzVEaHgtSU8xTEI4cEItdjRSVktFZjh5bmxETEtubjAtVGYzVGYxM0laY1dkUFQ1TEJZMXBEQkNEWEZjTEEyTkk1enROa0xtbzUxYnc2eEVlQWRYQ2hjeUhfV3NTd0dPZ3A3M1pDcktxN19RakVGOExLWGVBWkxmRnp6VEQyemJXN1BJQm5wZlp6Q3FUZlRUUXJhWlp0aHBuMXlsRzRNRy1YRElJeEttblhscHhFdHVkRFpKam9OMHlSaGFGLXh0SUZ5akVwQlhVRmdlNzdnbFhleVdVMQ?oc=5","date":"2026-02-27","type":"pipeline","source":"GlobeNewswire","summary":"AIM ImmunoTech Reminds Stockholders of March 3, 2026 - GlobeNewswire","headline":"AIM ImmunoTech Reminds Stockholders of March 3, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9BYWhnV2tSZ3lVYjBlckJjYWZkbUhvN3dJME5OVDVZV2Z5Mld6QVo0eTJWNTRFcGJsR0t2UkZ0NlZMeEZmSWU1MzVrYXBPd0tOV0tvNXdYSFp6OVQ2eWfSAWNBVV95cUxNbmJYS1NlcmJETGhYVTIxdm5Ob0VUWXVremExckNnNjktNEhINTZBUFpmSldRSTgyM21vbjhZNlNZOHlIS0loSnVEM0RzaFpvSmJWMW1Hd0dtVEQ1WHFCWjhaSU0?oc=5","date":"2026-02-12","type":"pipeline","source":"Bitget","summary":"CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering - Bitget","headline":"CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-12","type":"pipeline","source":"The Manila Times","summary":"AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event - The Manila Times","headline":"AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-11","type":"pipeline","source":"The Manila Times","summary":"AIM ImmunoTech Announces Commencement of Rights Offering - The Manila Times","headline":"AIM ImmunoTech Announces Commencement of Rights Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNRG5hMlZBazhvR1RUUDAtbnBaRjJYNDVTS19Xclo0bjRuRUdjYjBxbUZ4MlFPVWk4QXo5V3poRE9yTDNvRmtKRXJrV3Z6VHVzb3RCSnJJbWJfNnJnck0xRktpR0pLbVFtdHV6N09EMTI5Q0NWb3c3SnRld0ViazNJczZmblZQX3luM3VJZWQ0bmdJVE9QRHl4TmJ1Vzc3TXNoaVpMb2IzbFUwczFuYkdTMGstVWN2bGdz?oc=5","date":"2026-02-06","type":"pipeline","source":"Stock Titan","summary":"Pancreatic cancer focus: AIM ImmunoTech CEO joins Webull live webinar - Stock Titan","headline":"Pancreatic cancer focus: AIM ImmunoTech CEO joins Webull live webinar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxNSUxiVFdFdlNkX3F1SEVkRWVlNkZLaEJkNk1iY0xpeTRPMkRCSFAzVm9ZSlp4cl9RUnpUUElRdko3SF81ZF9mSzhYQVI4U3BaUzFUT21udmg1dWF4czZJUWNLOVRGbTBqMWxJRWJZSUJjdVhSOXFMMF96OV9nMVlyUjJ4Vm5kUEgxODA0VmxpNG1XbE5ScFpQalNiaG9JelBxb0kwM3I0SlM0aVpLcXdQYjNrbjJrbUFuUldQS2xjWEtQRFpjUFFDZTVBRWtIbE04dDluNnVOZWxHbElJNW81b2pJLVFOWWFCQ3hFdVd3?oc=5","date":"2026-01-23","type":"pipeline","source":"GlobeNewswire","summary":"AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering - GlobeNewswire","headline":"AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBNY25rZTJkeHNiaHBOREVzNF9vSU1uSWlMQ2ptQXlRZ1p1d1pJRkVMXzVCb3hjdW15VmJydnVWeWk5X0JnOUZGOWFzUjdjc2VUR19j?oc=5","date":"2025-04-28","type":"pipeline","source":"Stock Titan","summary":"AIMI Stock Price, News & Analysis - Stock Titan","headline":"AIMI Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPb0pmaENTaEw5V043UGFkX21GeXJ3V0p4VmwyaktzcFpKN0swMGtvV29lRjM4c2NJUGp1YWNSTTJHbjFvYWx4bWZKQzBtUEY5TDZ2YjI1LU1IMHlWQWNheHFkV1RyN1NmemhUTFdheVJJbjlWcVlUa3NTV285NFpGTzRTVnpUMWM1N19xVDgzcFVTclFaSHdyN3J2MTAxT3dCVzBzcw?oc=5","date":"2024-12-20","type":"pipeline","source":"The Business Journals","summary":"Ted Kellner low-key on joining pharma firm board he fought to join - The Business Journals","headline":"Ted Kellner low-key on joining pharma firm board he fought to join","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTE1XUm9vNW1Ga0hkZnZIMktZX2s3MUlNT2JFMmhIVkFVX2xkNm5Cc3YwSFhxTXRXOFhUVlBtZ2ViWWw4SDYzejYxQ1NFWVZKWm8?oc=5","date":"2024-03-02","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}